REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Qualifying Blood Screening NAT Assays for Safety Testing of Cellular Based Therapeutics

Leave a Reply

Your email address will not be published. Required fields are marked *

Search
Close this search box.